**12. Summary**

temporary effect if the uveitis persists, since new inflammatory products may gradually ob‐

These devises are placed into the suprachoroidal space. Based on other devises with similar principle, it is expected that these devices will fail due to obstruction by uveal tissue espe‐

Cycloablation, preferably with 810nm infrared diode laser may be applied in uncontrolled glaucoma with no potential for improvement in visual acuity in which other anti-glaucoma procedures failed. [58], [59] The reason is that it is difficult to predict the outcome of the treatment (final IOP) and to control the post-treatment intraocular inflammation, which is usually, exacerbate. Such inflammation may result in CME with decrease in visual acuity and central scotoma, papillary and retropupillary membranes and phthisis bulbi. The initial settings for trans-scleral cyclophotocoagulation with this laser is 1,250mW, 2sec. Following topical anesthesia and additional peribulbar lidocaine 2% 2ml, the probe is placed 1.2mmbe‐ hind the limbus. The power is increased in 150mW increments but not over 2250mW until a "pop" sound is heard. Then it is decreased in 150mW until no "pop" is heard and treatment begins. Eighteen spots are delivered to 270° avoiding 3:00 and 9:00 positions where the long posterior ciliary nerves enter the eye. Prevention of CME may be possible by topical NSAID such as diclofenac sodium (Voltaren®) 0.1% qid for 6 months. Decrease in visual acuity mayoccur from CME if prophylactic treatment is refrained or in cases of advanced visual field loss (splitting of the fixation or high mean deviation) as in other surgical procedures.

The follow-up intervals depend on the severity of the uveitis and glaucoma. Patients with quiet eyes and controlled IOP should be observed at least every 6 months. If the uveitis is active or the glaucoma is uncontrolled, the follow-up interval should be decreased. The fol‐ low-up examinations include IOP measurement, complete anterior and posterior segments for activity of the uveitis, optic disc cupping and other means as necessary (e.g., visual fields

The prognosis depends on the etiology of the uveitis and severity of the inflammation and the glaucoma. Early medical and surgical interventions may improve the visual outcome

and obtain resolution or long-term remission of the uveitis.

struct the surgical site.

372 Glaucoma - Basic and Clinical Aspects

cially in eyes with uveitis.

**9.5. Cycloablation**

**10. Follow-up**

and OCT).

**11. Prognosis**

**9.4. Solx Gold shunt and CyPass**

Uveitic glaucoma is a heterogeneous group of diseases in which glaucoma develops secon‐ dary to uveitis. The diagnosis is based on elevated IOP. Periodic evaluation of the optic disc should be made, and in patients with cup/disc ratio of 0.6 or more, visual field evaluations should be obtained. The management includes treating the uveitis, glaucoma and the under‐ lying disorder. Most of the uveitis types should be treated although uveitis in juvenile rheu‐ matoid arthritis requires minimal medical treatment to obtain remission and the uveitis in Fuchs' heterochromic iridocyclitis does not require any treatment. In contrary, glaucoma should always be treated aggressively. If medical treatment for glaucoma fails, surgical in‐ tervention should be promptly applied. Evaluation of the newer procedures and implants is required to determine the best approach.
